Osimertinib (osi) after definitive chemoradiotherapy (CRT) in patients (pts) with unresectable stage (stg) III epidermal growth factor receptor-mutated (EGFRm) NSCLC: Primary results of the phase 3 LAURA study

Ramalingam S. S., Kato T., Dong X., Ahn M., Quang L., Soparattanapaisarn N., ...Daha Fazla

JOURNAL OF CLINICAL ONCOLOGY, sa.17_SUPPL, 2024 (SCI-Expanded, Scopus)

• Yayın Türü: Makale / Özet
• Basım Tarihi: 2024
• Doi Numarası: 10.1200/jco.2024.42.17_suppl.lba4
• Dergi Adı: JOURNAL OF CLINICAL ONCOLOGY
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, CAB Abstracts, CINAHL, Gender Studies Database, International Pharmaceutical Abstracts, Veterinary Science Database
• İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır